Search

everythinglearnresearchcommunity

for

Search:↓

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

Topical finasteride helps regrow hair and reduce hair loss in men and women.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Combining topical dutasteride with microneedling is more effective for hair growth than microneedling alone.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Niosomes improve minoxidil skin delivery for hair loss treatment.

Liposomes better deliver minoxidil for hair loss treatment than niosomes.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Using both minoxidil and finasteride together is more effective for male hair loss than using either one alone.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

DCPA is a chronic skin condition affecting the legs, often misdiagnosed, and needs more research for better understanding and treatment.

Exosomes are important for skin treatments and hair growth but need more research for safe and effective use.

PRP is more effective than minoxidil and placebo for treating hair loss.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Microneedling with PRP is as effective and safe as minoxidil+finasteride for treating hair loss.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Clofazimine may be effective for treating ashy dermatosis.